RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination (MACH19)
Multicenter Double-Blind, Placebo-Controlled RCT of Fomitopsis Officinalis/Trametes Versicolor for COVID-19
Sponsor: University of California, San Diego
A NA clinical study on COVID-19 Vaccination, this trial is completed. The trial is conducted by University of California, San Diego and has accumulated 10 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Sep 2023 — Jun 2024 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Dec 2022 — Sep 2023 [monthly]
Active Not Recruiting NA
-
Mar 2022 — Dec 2022 [monthly]
Active Not Recruiting NA
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Nov 2021 — Feb 2022 [monthly]
Recruiting NA
Phase: PHASE2 → NA
-
Sep 2021 — Nov 2021 [monthly]
Recruiting PHASE2
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Diego
For direct contact, visit the study record on ClinicalTrials.gov .